Howard Goldman, MD, FACS

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Female Pelvic Medicine & Reconstructive Surgery)
    Ineligible company: 
    Direx
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    06/08/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Female Pelvic Medicine & Reconstructive Surgery)
    Ineligible company: 
    vensica
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    06/08/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Female Pelvic Medicine & Reconstructive Surgery)
    Ineligible company: 
    sacramed
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    06/08/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Female Pelvic Medicine & Reconstructive Surgery)
    Ineligible company: 
    urovant
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    06/08/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Specialty Not Specified)
    Ineligible company: 
    Laborie
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    06/08/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Specialty Not Specified)
    Ineligible company: 
    Boston Scientific
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    06/08/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Specialty Not Specified)
    Ineligible company: 
    Bluewind
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    06/08/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Specialty Not Specified)
    Ineligible company: 
    NewUro
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    06/08/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Specialty Not Specified)
    Ineligible company: 
    allergan
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    06/08/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Specialty Not Specified)
    Ineligible company: 
    Medtronic
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    06/08/2022
Return to Annual Review Course (2022)